Valuation Collegium Pharmaceutical, Inc.

Stocks

Real-time Estimate Cboe BZX 09:13:53 09/09/2026 pm IST			5-day change	1st Jan Change
23.79 ^USD	+1.80%		-2.63%	-48.90%

05:26pm	Leerink Partners Initiates Coverage on Collegium Pharmaceutical With Outperform Rating, $45 Price Target	MT
04:59pm	Truist Cuts Price Target on Collegium Pharmaceutical to $49 From $58, Keeps Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	650	778.9	1,004	924	1,464	760.8	-	-
Change	-	19.82%	28.87%	-7.95%	58.4%	-48.02%	-	-
Enterprise Value (EV)	650	778.9	1,004	924	1,464	760.8	760.8	760.8
Change	-	19.82%	28.87%	-7.95%	58.4%	-48.02%	0%	0%
P/E	10x	-31.4x	23.9x	15.4x	26.8x	-	-	-
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	-0x	0.3x	-3.83x	-	-	-
Capitalization / Revenue	2.35x	1.68x	1.77x	1.46x	1.88x	0.91x	0.92x	0.93x
EV / Revenue	0x	0x	0x	0x	0x	0.91x	0.92x	0.93x
EV / EBITDA	0x	0x	0x	0x	0x	1.67x	1.91x	2.22x
EV / EBIT	0x	0x	0x	0x	0x	1.69x	1.88x	2.02x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.86	-0.74	1.29	1.86	1.73	-	-	-
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	276.9	463.9	566.8	631.4	780.6	836.8	828.1	820.2
EBITDA ¹	118.3	266	367	401.2	460.5	455.8	399.4	342.7
EBIT ¹	17.63	33.32	167	169.9	179.6	450.8	404.7	376.5
Net income	71.52	-25	48.16	69.19	62.87	-	-	-
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	18.68	23.20	30.78	28.65	46.30	23.37	23.37	23.37
Nbr of stocks (in thousands)	34,797	33,572	32,611	32,250	31,611	32,556	-	-
Announcement Date	24/02/22	23/02/23	22/02/24	27/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
COLLEGIUM PHARMACEUTICAL, INC.	-	-	-	-	76Cr
ELI LILLY AND COMPANY	31.99x	11.64x	23.74x	0.62%	1,00200Cr
JOHNSON & JOHNSON	29.94x	-	-	2%	65TCr
ABBVIE INC.	31.86x	7.4x	15.38x	2.76%	44TCr
ROCHE HOLDING AG	19.06x	4.64x	11.51x	2.86%	35TCr
NOVARTIS AG	19.62x	5.13x	12.72x	3.16%	26TCr
ASTRAZENECA PLC	20.69x	4.25x	12.14x	2.08%	25TCr
AMGEN INC.	24.87x	6.52x	11.97x	2.57%	21TCr
NOVO NORDISK A/S	13.02x	4.72x	9.85x	3.87%	20TCr
GILEAD SCIENCES, INC.	-44.81x	6.47x	25.27x	2.25%	18TCr
Average	16.25x	6.35x	15.32x	2.46%	35.44TCr
Weighted average by Cap.	23.18x	7.75x	17.28x	2.03%